3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
6
Lymphoma, Non-Hodgkin
6
Rhabdoid Tumor
5
Neuroectodermal Tumors, Primitive, Peripheral
5
Neuroblastoma
5
Medulloblastoma
5
Histiocytosis, Langerhans-Cell
5
Hepatoblastoma
5
Glioma
5
Ependymoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Osteosarcoma
4
Lymphoma
4
Central Nervous System Neoplasms
4
Sarcoma, Ewing
3
Multiple Myeloma
3
Lung Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neuroendocrine Tumors
2
Malignant Solid Neoplasm
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Burkitt Lymphoma
2
Xanthogranuloma, Juvenile
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Interventions
Ipilimumab
96
pembrolizumab
82
Nivolumab
79
aldesleukin
51
Cyclophosphamide
49
Interleukin-2
38
fludarabine phosphate
31
Vemurafenib
31
Dacarbazine
31
dabrafenib
29
trametinib
28
Temozolomide
26
fludarabine
25
CTLA-4 Antigen
18
Bevacizumab
18
Radiosurgery
15
Paclitaxel
15
Carboplatin
14
encorafenib
13
binimetinib
13
Introns
13
talimogene laherparepvec
12
Interferon alpha-2
12
Radiotherapy
11
spartalizumab
10
cobimetinib
10
atezolizumab
10
sargramostim
9
peginterferon alfa-2b
9
montanide ISA 51
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Melanoma
×
X-Rays
×
Clear all
No trials found.